pasireotide LA

Trials studying pasireotide LA

• phase2A Study of Pasireotide in People With Prolactinomarecruitingn=10
• phase1Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampulecompletedn=40
• phase2Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemiaactive not recruitingn=93
• phase2Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancerterminatedn=6
• phase1A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310completedn=42
• —Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Diseasecompletedn=152
• phase4Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studiescompletedn=337